Document text
Principal Investigator: LAURA J ESSERMAN
Organization: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Fiscal Year: 2024
Award: $1,741,554
Funding agency: National Cancer Institute
PROJECT SUMMARY/ABSTRACT
The WISDOM Study (Women Informed to Screen Depending on Measures of risk) is a
pragmatic trial comparing a personalized approach to breast cancer screening – in which the
intensity and modality of screening is dependent upon stratified personal risk -- against the gold
standard of annual screening. The goal is to determine whether a personalized approach is as
safe, less morbid, better accepted by women, encourages uptake of preventive interventions,
and is of higher health care value (better outcomes at less cost psychologically, physically, and
financially).
In this proposal `Expanding the WISDOM Study's Diversity, Reach, and Generalizability', we are
seeking support to expand the study to additional sites around the country to enhance
recruitment, improve study power and increase both the geographic and population diversity of
study participants. By doing so, our intention is to increase the generalizability of the study
results. Using a unique coverage with evidence progression model, we have secured insurance
coverage and outreach collaboration from multiple payers, giving us the opportunity to enroll
from an additional population of ~6 million women across multiple regions and varied ethnic and
socioeconomic backgrounds. The network of sites that this proposal will enable us to add will
allow us to create a collaborative group to continuously improve screening and learn who is at
risk for what kind of cancer.
The personalized screening arm includes a risk assessment based on family history, exposures,
breast density, co-morbidity and genetic predisposition (presence of mutations in the 9 genes
associated with screening and the combination of the small variation in inherited genes, the
single nucleotide polymorphisms, into a polygenic risk score or PRS). Importantly, the PRS
score is tailored to different ethnicities based on advances in the science of risk assessment,
allowing us to translate these important findings into practice. We are using an adaptive
approach in which the risk model is updated over the course of the trial as new information
emerges. The personalized approach yields an integrated risk score that allows us to assign an
age to start, an age to stop, a frequency of screening, and a modality for screening.
The R01 Specific Aims are to:
1. Open new clinical sites with experience enrolling targeted populations and use culturally
targeted materials to increase the numbers in and diversity of the WISDOM study
population
2. Enhance trial enrollment and retention through national partnerships, centralized campaigns
across the network and embedded analytics with real time feedback
Terms: <Adopted><Adoption><Advocate><Age><Alabama><Blue Cross><Blue Shield><Boston><Breast><Breast Cancer><Breast Cancer Detection><Breast Cancer Risk Factor><Breast Cancer Treatment><Breast cancer screening><Breast screening><California><Cancer Biology><Cancers><Caring><Chicago><Clinical><Clinical Services><Collaborations><Conflict><Conflict (Psychology)><Confusion><Confusional State><Contracting Opportunities><Contracts><Country><Data><Disease><Disorder><Employee><Enrollment><Ethnic Origin><Ethnicity><Exhibits><Family><Feedback><Florida><Frequencies><Funding><Genes><Genetic Alteration><Genetic Change><Genetic Predisposition><Genetic Predisposition to Disease><Genetic Susceptibility><Genetic defect><Genetic propensity><Geography><Goals><Guidelines><Health><Healthcare><Hereditary><History><Home><Illinois><Individual><Infrastructure><Inherited><Inherited Predisposition><Inherited Susceptibility><Insurance Carriers><Insurance Coverage><Insurance Status><Insurers><Intention><International><Internist><Investments><Knowledge><Learning><Louisiana><Malignant Breast Neoplasm><Malignant Neoplasms><Malignant Tumor><Mammogram><Mammography><Measures><Mental Confusion><Midwest><Midwest U.S.><Midwest US><Midwestern United States><Minnesota><Modality><Modeling><Modernization><Mutation><New Jersey><Oregon><Outcome><Palsy><Paralysed><Participant><Patient outcome><Patient-Centered Outcomes><Patient-Focused Outcomes><Personalized medical approach><Plegia><Population><Population Heterogeneity><Predisposition><Preventative intervention><Randomized><Recommendation><Recording of previous events><Research Institute><Risk><Risk Assessment><Risk Factors><Safety><Science><Secure><Single Base Polymorphism><Single Nucleotide Polymorphism><Site><Societies><South Carolina><Susceptibility><Target Populations><Technology><Testing><Time><Traction><Translating><United States><United States Department of Veterans Affairs><United States Veterans Administration><Universities><Update><Utah><Variant><Variation><Veterans><Veterans Administration><Veterans Affairs><Washington><Woman><ages><annual screening><arm><breast cancer risk><breast density><cancer predisposition><clinical research site><clinical site><co-morbid><co-morbidity><comorbidity><continuous learning><cost><customized therapy><customized treatment><demographics><design><designing><diverse populations><enroll><experience><genetic etiology><genetic mechanism of disease><genetic vulnerability><genetically predisposed><genome mutation><health care><heterogeneous population><high risk><histories><homes><improved><individualized approach><individualized medicine><individualized patient treatment><individualized therapeutic strategy><individualized therapy><individualized treatment><innovate><innovation><innovative><intervention for prevention><knowledge translation><learning progression><malignancy><malignant breast tumor><mammary cancer detection><mammary screening><mammographic Imaging><mammographic examinations><mammographic exams><neoplasm/cancer><outreach><paralysis><paralytic><patient centered><patient oriented><patient oriented outcomes><patient specific therapies><patient specific treatment><personalized approach><personalized screening><polygenic risk score><population based><population diversity><pragmatic effectiveness trial><pragmatic trial><precision approach><precision medicine><precision screening><precision-based medicine><preference><prevention intervention><preventional intervention strategy><preventive intervention><programs><psychologic><psychological><randomisation><randomization><randomly assigned><recommended screening><recruit><routine screening><screening><screening guidelines><screening recommendations><screenings><single nucleotide variant><socio-economic><socio-economically><socioeconomically><socioeconomics><study population><tailored approach><tailored medical treatment><tailored therapy><tailored treatment><testing services><trial comparing><trial design><trial enrollment><unique treatment><uptake>